Published in Front Aging Neurosci on February 07, 2017
Leucine-Rich Repeat Kinase 2 (LRRK2) Stimulates IL-1β-Mediated Inflammatory Signaling through Phosphorylation of RCAN1. Front Cell Neurosci (2017) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Brain (2011) 2.76
Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models. Nat Genet (2007) 1.53
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay. Mol Neurodegener (2015) 1.45
Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients. J Alzheimers Dis (2009) 1.07
Protective mechanisms by cystatin C in neurodegenerative diseases. Front Biosci (Schol Ed) (2011) 1.05
A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. Prog Neurobiol (2013) 1.03
Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults. Front Aging Neurosci (2010) 1.03
Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions. Neurology (2014) 1.02
Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis. Autophagy (2011) 1.00
Understanding the neuroinflammatory response following concussion to develop treatment strategies. Front Cell Neurosci (2012) 0.99
Serum cystatin C and the risk of Alzheimer disease in elderly men. Neurology (2008) 0.99
Relation of neuropathology with cognitive decline among older persons without dementia. Front Aging Neurosci (2013) 0.98
Protection after stroke: cellular effectors of neurovascular unit integrity. Front Cell Neurosci (2014) 0.97
Apo-Eε4 allele in conjunction with Aβ42 and tau in CSF: biomarker for Alzheimer's disease. Curr Alzheimer Res (2011) 0.95
Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy. Am J Pathol (2010) 0.94
Cystatin C in Alzheimer's disease. Front Mol Neurosci (2012) 0.94
Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies. Neurobiol Dis (2005) 0.93
Contra-Directional Expression of Serum Homocysteine and Uric Acid as Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study. Front Cell Neurosci (2015) 0.93
Cystatin C is released in association with exosomes: a new tool of neuronal communication which is unbalanced in Alzheimer's disease. Neurobiol Aging (2009) 0.92
Involvement of dopaminergic neuronal cystatin C in neuronal injury-induced microglial activation and neurotoxicity. J Neurochem (2012) 0.91
Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits. Brain (2014) 0.89
Interactions of metals and Apolipoprotein E in Alzheimer's disease. Front Aging Neurosci (2014) 0.88
Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies. Prog Neurobiol (2015) 0.88
High-density lipoproteins and cerebrovascular integrity in Alzheimer's disease. Cell Metab (2014) 0.87
CSF ubiquitin as a specific biomarker in Alzheimer's disease. Curr Alzheimer Res (2014) 0.86
Plasma cystatin C and risk of developing Alzheimer's disease in subjects with mild cognitive impairment. J Alzheimers Dis (2010) 0.86
Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls. J Alzheimers Dis (2010) 0.85
HDL and cognition in neurodegenerative disorders. Neurobiol Dis (2014) 0.84
Plasma levels of HDL and carotenoids are lower in dementia patients with vascular comorbidities. J Alzheimers Dis (2014) 0.83
Systemic metabolism in frontotemporal dementia. Neurology (2014) 0.83
Lower Bone Mineral Density in Patients with Parkinson's Disease: A Cross-Sectional Study from Chinese Mainland. Front Aging Neurosci (2015) 0.83
Endogenous aggregates of amyloidogenic cystatin C variant are removed by THP-1 cells in vitro and induce differentiation and a proinflammatory response. Neurobiol Aging (2012) 0.81
Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy. PLoS One (2013) 0.81
SUMOylation: Novel Neuroprotective Approach for Alzheimer's Disease? Aging Dis (2015) 0.80
Serum Homocysteine, Dehydroepiandrosterone Sulphate and Lipoprotein (a) in Alzheimer's Disease and Vascular Dementia. Aging Dis (2013) 0.80
Attenuation of early brain injury and learning deficits following experimental subarachnoid hemorrhage secondary to Cystatin C: possible involvement of the autophagy pathway. Mol Neurobiol (2013) 0.80
HDL subfractions and very early CAD: novel findings from untreated patients in a Chinese cohort. Sci Rep (2016) 0.78
Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients. Front Aging Neurosci (2016) 0.76
Activated regulatory T cell regulates neural stem cell proliferation in the subventricular zone of normal and ischemic mouse brain through interleukin 10. Front Cell Neurosci (2015) 0.78
Methylene blue promotes quiescence of rat neural progenitor cells. Front Cell Neurosci (2014) 0.77